Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedNov 25, 2024
DataAggregated Company Financials
Companies2
- 7D7.1%
- 3M87.3%
- 1Y144.7%
- YTDn/a
In the last week, the Pharma industry is up 7.1%, with all of the companies up. This takes the industry's 12 month performance to a gain of 145%.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 Nov 2024 | AR$155.2b | AR$42.6b | AR$18.2b | 6.9x | 8.5x | 3.6x |
| Wed, 23 Oct 2024 | AR$83.0b | AR$40.7b | AR$4.6b | 14.3x | 18.2x | 2x |
| Fri, 20 Sep 2024 | AR$78.8b | AR$40.7b | AR$4.6b | 12.9x | 17.3x | 1.9x |
| Sun, 18 Aug 2024 | AR$85.6b | AR$52.7b | AR$2.3b | 34.4x | 37.9x | 1.6x |
| Tue, 16 Jul 2024 | AR$84.6b | AR$41.1b | -AR$3,264,658,797.00 | 4.6x | -25.9x | 2.1x |
| Thu, 13 Jun 2024 | AR$85.0b | AR$41.1b | -AR$3,264,658,797.00 | 4.5x | -26x | 2.1x |
| Sat, 11 May 2024 | AR$77.7b | AR$43.6b | -AR$10,287,966,966.00 | 9.2x | -7.5x | 1.8x |
| Mon, 08 Apr 2024 | AR$77.8b | AR$9.6b | -AR$4,702,241,388.00 | 58.1x | -16.5x | 8.1x |
| Wed, 06 Mar 2024 | AR$70.7b | AR$9.6b | -AR$4,702,241,388.00 | 50.6x | -15x | 7.3x |
| Fri, 02 Feb 2024 | AR$97.5b | AR$10.3b | -AR$4,704,193,685.00 | 56.8x | -20.7x | 9.4x |
| Sun, 31 Dec 2023 | AR$59.1b | AR$10.3b | -AR$4,704,193,685.00 | 33.6x | -12.6x | 5.7x |
| Tue, 28 Nov 2023 | AR$63.4b | AR$19.4b | -AR$4,675,725,481.00 | n/a | -13.6x | 3.3x |
| Thu, 26 Oct 2023 | AR$55.5b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -22.2x | 4.3x |
| Sat, 23 Sep 2023 | AR$43.0b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -17.2x | 3.3x |
| Mon, 21 Aug 2023 | AR$49.0b | AR$18.8b | -AR$150,001,147.00 | 15.4x | -326.6x | 2.6x |
| Wed, 19 Jul 2023 | AR$44.2b | AR$18.8b | -AR$150,001,147.00 | 13.2x | -294.4x | 2.3x |
| Fri, 16 Jun 2023 | AR$42.0b | AR$19.1b | AR$209.1m | 136.4x | 200.8x | 2.2x |
| Sun, 14 May 2023 | AR$33.4b | AR$19.1b | AR$209.1m | 107.2x | 159.8x | 1.7x |
| Tue, 11 Apr 2023 | AR$32.0b | AR$19.1b | AR$209.1m | 102.6x | 153.2x | 1.7x |
| Thu, 09 Mar 2023 | AR$30.5b | AR$13.7b | AR$1.5b | 16.7x | 19.7x | 2.2x |
| Sat, 04 Feb 2023 | AR$32.3b | AR$13.7b | AR$1.5b | 17.4x | 20.9x | 2.4x |
| Mon, 02 Jan 2023 | AR$32.0b | AR$13.8b | AR$1.5b | 20.9x | 21.3x | 2.3x |
| Wed, 30 Nov 2022 | AR$27.9b | AR$19.6b | AR$1.4b | 20.1x | 20.5x | 1.4x |
| Fri, 28 Oct 2022 | AR$27.9b | AR$19.7b | AR$1.4b | 23.2x | 20.2x | 1.4x |
| Sun, 25 Sep 2022 | AR$24.9b | AR$19.7b | AR$1.4b | 24.3x | 18x | 1.3x |
| Tue, 23 Aug 2022 | AR$22.0b | AR$17.8b | AR$987.0m | 25.5x | 22.3x | 1.2x |
| Thu, 21 Jul 2022 | AR$21.2b | AR$17.6b | AR$940.9m | 21.4x | 22.6x | 1.2x |
| Sat, 18 Jun 2022 | AR$20.0b | AR$9.9b | AR$101.3m | 150.6x | 197x | 2x |
| Mon, 16 May 2022 | AR$19.6b | AR$9.9b | AR$101.3m | 147.5x | 193.7x | 2x |
| Wed, 13 Apr 2022 | AR$19.3b | AR$9.9b | AR$101.3m | 146.1x | 191x | 1.9x |
| Fri, 11 Mar 2022 | AR$21.2b | AR$9.9b | AR$101.3m | 159.3x | 209.1x | 2.1x |
| Sun, 06 Feb 2022 | AR$20.5b | AR$9.9b | AR$101.3m | 153x | 202.1x | 2.1x |
| Tue, 04 Jan 2022 | AR$18.9b | AR$9.9b | AR$101.3m | 141.9x | 186.4x | 1.9x |
| Thu, 02 Dec 2021 | AR$19.2b | AR$7.0b | AR$393.1m | 45.9x | 48.8x | 2.7x |
Price to Earnings Ratio
48.8x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 259% per year over the last three years.
- Revenues for these companies have grown 82% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | 7.57% | |
| Healthcare | 7.10% | |
| Pharma | 7.10% | |
| Pharma | 7.10% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RICH Laboratorios RichmondC.I.F | AR$1.86k | 6.9% +AR$9.7b | 157.3% | PE8.7x | |
| ROSE Instituto Rosenbusch | AR$118.00 | 13.5% +AR$596.3m | 103.8% | PE5x |